Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2025
T lymphocyte-specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4<sup>+</sup> T cells and impairs antitumor responseConnor J R Foster, Jasper Du, Oscar Pundel, et al.Journal for Immunotherapy of Cancer|September 20, 2017
Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancerAndrew Zloza, A Karolina Palucka, Lisa M Coussens, et al.Cancer Research|April 24, 2023
Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in MelanomaHa-Ram Park, Anahita Shiva, Portia Cummings, et al.Frontiers in Immunology|October 5, 2020
HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural EffusionsAdam C Soloff, Katherine E Jones, Amy A Powers, et al.Nature Communications|March 21, 2024
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomasMarina T Broz, Emily Y Ko, Kristin Ishaya, et al.Nature Genetics|August 5, 2022
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironmentDalia Barkley, Reuben Moncada, Maayan Pour, et al.Advanced Materials (Deerfield Beach, Fla.)|June 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune ResponseWorapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
A targetable developmental program co-regulates angiogenesis and immune evasionPietro Berico, Amanda Flores Flores Yanke, Fatemeh Vand Rajabpour, et al.Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.Pageof 9